生物製药物流市场报告：2030 年趋势、预测与竞争分析

生物製药物流趋势及预测

预计到 2030 年，全球生物製药物流市场将达到 1,292 亿美元，2024 年至 2030 年复合年增长率为 7.5%。该市场的主要驱动力是精准医疗和基因治疗的兴起、家庭医疗用品需求的成长以及外包物流业务的成长趋势。全球生物製药物流市场的未来前景广阔，製药、生物製药、药局、医院、诊所和超级市场市场都有机会。

Lucintel预测，由于对温控产品的需求不断增加以及需要精确的温控物流服务以确保产品有效性，低温运输物流将在预测期内出现高速增长。

在这个市场中，预计药品在预测期内将出现最高成长。

由于该地区医药产品进出口不断扩大，预计北美在预测期内仍将是最大的地区。

生物医学流市场新趋势

改变市场需求的新兴技术正在推动生物製药物流市场提高效率、合规性和服务品质的主要趋势。与此主张相关的一些最常见的趋势包括：

• 先进的低温运输技术：我们开发了先进的低温运输低温运输，包括物联网感测器和自动温度控制系统，以增强我们在整个供应链中维持严格温度要求的能力。它还确保对温度敏感的生物製药的完整性和有效性，减少变质的机会，并有助于满足监管标准。
• 整合区块链技术：生物製药物流正在寻求以提高可追溯性和完全透明度的方式整合区块链技术。区块链描述了交易和产品移动的永久记录。区块链可以防止假冒，提高记录的准确性，确保生物製药产品整个供应链的真实性和安全性。人工智慧和自动化的应用现代人工智慧越来越多地应用于物流和营运的最佳化，例如库存管理、路线规划和预测性维护。人工智慧和自动化提高了交付计划的可靠性，同时提高了业务效率，减少了人为错误，并增强了决策以降低成本。
• 生物製药电子商务的成长：电子商务的成长开始影响生物製药物流。这一趋势要求物流和供应商适应新的交付方式，包括最后一哩交付解决方案，并实施能够解决直接向患者交付的独特挑战的系统。
• 加强监管合规性：高度重视确保完全遵守各个地区严格的监管标准，例如温度控制、文件记录和报告要求。监管合规性的提高导致了更复杂的物流解决方案的发展，需要更详细的文件并符合国际标准，以确保生物製药的安全和品质。
• 这些趋势使供应链更加有效、透明且符合法规，从而显着改变了生物製药物流市场格局。随着技术发展的不断进步，这些新趋势将进一步扩大行业内的创新和适应范围，以满足世界对生物製药不断变化的需求。
• 生物医学流市场近期趋势
• 生物製药物流市场的最新趋势是由技术进步、监管变化和不断变化的行业需求所驱动的。
• 低温运输创新：低温运输技术的显着增强，例如先进的温控包装和基于物联网的监控系统，使生物製药物流服务更加可靠。这些创新确保对温度敏感的产品在最佳条件下得到维护和运输，以保持其完整性，最大限度地减少损坏和合规问题。
• 数位化和即时追踪：物流领域正在逐渐转变为数位工具和即时追踪系统的世界。 RFID 和 GPS 是用于追踪货物位置和状况的一些技术。即时追踪提高了供应链的可视性，并能够及时干预和管理预期的中断。
• 扩大物流网络：物流网络正在扩大，转向建立新的物流中心和发展更好的交通基础设施。扩大网路的优势在于，可以确保更快分配产品的效率，以满足全球经济对产品的需求。
• 采用人工智慧和机器学习：人工智慧和机器学习技术的应用可以优化物流业务，例如需求预测、路线优化和库存管理。这些技术有助于提高业务效率、降低成本并提高物流和流程管理的准确性。
• 监管适应：生物製药物流的新挑战是改善温度控制和文件管理的法律规范的核心。监管调整旨在确保更高水准的安全和品质标准并开发更先进的物流解决方案。
• 这些趋势对提高生物製药物流市场的业务效率、合规性和整体服务品质做出了重大贡献。这些新兴市场的开拓预计将支持生物製药产业的新需求，并为该市场的物流业务带来更高的可靠性。
• 生物医学流市场的策略性成长机会
• 生物製药物流市场透过多种不同的应用提供了各种策略性成长机会，显示对先进物流解决方案和技术创新的需求不断增长。
• 低温运输管理：投资先进的低温运输管理解决方案带来了巨大的成长机会。主动冷却系统和即时监控等技术可以确保温度敏感产品的完整性。改进的低温运输管理有助于确保药品保持在非常窄的温度范围内，同时最大限度地减少废弃物，以满足对生技药品和个人化医疗不断增长的需求。
• 电子商务和直接面向患者的运输：电子商务和直接面向患者模式的成长趋势正在为专业物流提供者创造新的机会。开发高效的最后一哩交付解决方案，以跟上家庭护理趋势。这个不断成长的市场需要便利性和直接的交付选择。这些选项需要能够处理复杂的交付要求和患者互动的物流解决方案。
• 高阶资料分析：在物流业务中利用高阶资料分析的力量是一个明显的成长机会。分析透过更好地进行需求预测、路线规划甚至库存管理来进一步优化物流业务。提高资料分析能力将带来更有效率的物流业务、减少浪费费用和更好的决策，推动整个生物製药产业的成长。
• 自动化和机器人技术：透过将自动化和机器人技术引入物流业务，可以实现更大的成长空间。仓储、分类和运输的自动化系统变得更有效率和准确。自动化对于企业来说是一项有前途的投资，可以确保平稳运营，因为它可以透过减少人为错误来降低营运成本并提高物流流程的速度。
• 监管合规解决方案：确保您拥有符合不断发展的监管标准的解决方案，为成长扫清道路。这包括透过技术追踪、报告和维护品质标准。合规解决方案可协助物流提供者满足严格的法规，同时降低与违规相关的风险，并确保生物製药交付的安全性和生产力。
• 这些新的成长机会将决定生物製药物流市场的未来方向，无论是透过识别和开拓新需求还是透过技术进步。随着市场的发展，这些新机会将推动生物製药物流的创新和可靠性提高效率。
• 生物医学流市场推动因素及挑战
• 有许多技术、经济和监管因素正在推动生物製药物流市场的成长，同时也带来了重大挑战。主要驱动因素包括技术进步和对生物製药的需求增加，而高昂的实施成本、资料安全和复杂的监管合规性是显着的挑战。了解这些动态将有助于相关人员有效地穿越市场、利用机会并克服障碍。
• 推动生物製药物流市场的因素包括：

1. 技术进步：物联网、人工智慧和区块链是正在彻底改变生物製药物流领域的一些更广泛的技术。物联网感测器更准确、即时地监测温度，人工智慧优化路线规划和库存管理，区块链使链条中的每个环节高度透明且可追溯。这些增强功能提高了效率，减少了出错的可能性，并提高了对温度敏感的货物的完整性。因此，它满足了对更复杂的物流解决方案的需求，最终有助于使供应链更加可靠和有效率。

2. 生物製药的需求增加：显然，医学研究的进步、慢性病盛行率的上升以及世界人口的老化将增加对生物製药（例如生技药品和个人化药物）的需求。相应地，更多的高价值产品需要更专业的物流来管理复杂的供应链。

3. 扩大全球供应链的好处：供应链的全球化产生了对强大的生物製药物流解决方案的需求。随着公司拓展国际市场，他们需要一个能够管理跨境运输并确保满足各种监管标准的物流网络。高效的全球物流解决方案可实现及时交付并减少中断。这对于保持生物製药产品平臺畅通并满足全球客户群的要求是必要的。

• 生物製药物流市场的挑战包括：

1.技术实施成本高：物联网系统、区块链等先进技术的实施成本极高。成本包括一次性技术投资、持续维护以及与现有系统的整合。这些可能成为小型物流企业的进入障碍，而且成本可能非常高，限制了他们提供高科技解决方案的潜力。这可能会导致大小市场参与企业之间出现数位落差。

2.资料隐私和安全问题：生物製药物流的主要挑战之一是如何保护敏感的医疗资讯。确保资料隐私和安全需要采取适当的网路安全措施并遵守 GDPR 和 HIPAA 等各种法规。资料外洩和安全故障可能导致法律纠纷、失去信任和罚款。解决这些问题需要对安全技术和流程进行大量投资。

3. 监管合规的复杂性：不同的区域法规环境对生物製药公司的物流提供者构成了真正的挑战。有关处理、文件和运输的规定可能因国家而异。遵守所有相关法规需要大量的知识和资源。违规可能导致延误、罚款和市场进入问题。

• 生物製药物流市场的关键驱动因素包括技术发展、不断增长的需求和监管要求，而业务效率和全球供应链提供了显着的好处。然而，高昂的实施成本、资料安全问题和复杂的监管合规问题是该市场的缺点。平衡这些市场驱动因素和挑战是相关人员顺应市场发展并利用成长和创新机会的关键。
• 生医药流企业名录
• 市场上的公司透过其提供的产品品质进行竞争。该市场的主要企业专注于扩大製造设施、投资研发、开拓基础设施以及利用整个价值链的整合机会。透过这些策略，生物製药物流公司正在满足不断增长的需求、确保竞争、开发创新产品和技术、降低製造成本并扩大基本客群。本报告介绍的生物医学流企业如下。
• Kuehne+Nagel
• CH Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport

目录

第一章执行摘要

第二章 全球生物医学流市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球生物製药物流市场趋势（2018-2023）与预测（2024-2030）
• 按产品类型分類的全球生物製药物流市场
  • 低温运输物流
  • 非低温运输物流
• 按运输服务类型分類的全球生物製药物流市场
  • 运输
  • 仓储和储存
• 全球生物製药物流市场（依最终用途）
  • 药品
  • 生物製药
  • 药局
  • 医院
  • 诊所
  • 超级市场
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 生物医学流市场区域分布
• 北美生物医学流市场
• 欧洲生物医学药物流市场
• 亚太生物医药物流市场
• 其他地区生物医学药物流市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按产品类型分類的全球生物製药物流市场成长机会
  • 按运输服务类型分類的全球生物製药物流市场成长机会
  • 全球生物製药物流市场最终用途的成长机会
  • 全球生物製药物流市场按地区成长机会
• 全球生物医学流市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球生物製药物流市场的能力
  • 全球生物医药物流市场的合併、收购与合资
  • 认证和许可

第七章主要企业概况

• Kuehne+Nagel
• CH Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport

Biopharmaceutical Logistic Trends and Forecast

The future of the global biopharmaceutical logistic market looks promising with opportunities in the pharmaceutical, biopharmaceutical, pharmacy, hospital, clinic, and supermarket markets. The global biopharmaceutical logistic market is expected to reach an estimated $129.2 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are rising number of precision medicines and gene therapies, growing demand for household healthcare items, and augmenting trend of outsourcing logistical operations.

Lucintel forecasts that cold chain logistic is expected to witness the higher growth over the forecast period due to its increasing need for temperature-controlled products, necessitating precise temperature control logistics services to ensure the efficacy of the goods.

Within this market, pharmaceutical is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to expanding number of pharmaceuticals export and importation activity in the region.

Emerging Trends in the Biopharmaceutical Logistic Market

The advanced technologies that have caused a change in the landscape of market needs have driven the key trends of improving efficiency, compliance, and service quality in the biopharmaceutical logistics market. Some of the most prevailing observed trends in relation to the said proposition include:

• Advanced Cold Chain Technologies : Advanced cold chain technologies are being developed-including IoT sensors and automated temperature control systems-that enhance the capability to maintain strict temperature requirements through the supply chain. Besides, it ensures the integrity and effectiveness of temperature-sensitive biopharmaceutical products, lessening the potential for spoilage and making sure that they are able to conform to regulatory authority standards.
• Integration of Blockchain Technology: Biopharmaceutical logistics is going to integrate blockchain technology in ways that enhance traceability and total transparency. It provides a permanent record of transactions and product movements. Blockchain prevents counterfeits, improves record accuracy, and guarantees the authenticity and safety of a biopharmaceutical product through the supply chain. The applications of AI and Automation Description: Artificial Intelligence in recent times is finding its applications increasingly in optimizing logistics operation-inventory management, route planning, predictive maintenance. Artificial intelligence and automation raise operational efficiency, reduce human errors, and enhance decision-making for cost savings, while the reliability of delivery schedules is improved.
• Growth of E-commerce in Biopharma: Growth in e-commerce has begun to impact how the logistics of biopharmaceuticals work, particularly with regard to an increased demand for direct-to-patient delivery models and home-based treatments. The trend requires the adaptation of logistics providers to new methods of delivery, including last-mile delivery solutions, and to implement systems that can handle the unique challenges of direct-to-patient shipments.
• Increased Regulatory Compliance: High attention is being paid to making sure there is complete compliance with strict regulatory standards in various regions, including requirements in regard to temperature control, documentation, and reporting. Better regulatory compliance leads to the evolution of more complex logistics solutions, requiring more detailed documentation and compliance with international standards that ensure the safety and quality of biopharmaceutical products.
• These trends are restructuring the outlook of the biopharmaceutical logistics market by making supply chains more effective, transparent, and regulatory compliant. As technological development continues to keep pace, these emerging trends will further extend the area of innovation and adaptation within the industry as it meets the continuously changing needs around the world for biopharmaceuticals.
• Recent Developments in the Biopharmaceutical Logistic Market
• Recent developments in the biopharmaceutical logistics market are powered by technological advances, changes in regulations, and changing industrial needs.
• Cold Chain Innovation: There is great enhancement in cold chain technology, such as advanced temperature-controlled packaging and IoT-based monitoring systems, that raise the bar for the dependability of logistics services for biopharmaceuticals. These innovations ensure that temperature-sensitive products are maintained and transported under conditions optimal for preserving their integrity, thereby minimizing spoilage and compliance issues.
• Digitalization and Real-Time Tracking: The face of logistics is gradually metamorphosing into a world of digital tools and real-time tracking systems. RFID and GPS are some of the technologies being implemented to track both the location and condition of shipments. Real-time tracking improves supply chain visibility for timely intervention and management of expected disruptions.
• Expansion of Logistics Networks: Logistics networks are expanding, and there is a shift toward setting up new distribution centers and developing better transportation infrastructure. The advantages of extended networks are that it ensures the efficiency of distributing the products at a faster pace to meet the demand of the product in the global economy.
• Adoption of AI and Machine Learning: AI and machine learning technologies are being adopted in ways that enable the logistics operations to be optimized, including demand forecasting, route optimization, and inventory management. These technologies contribute to increased operational efficiency, cost reduction, and heightened accuracy in the management of logistics processes.
• Regulatory Adaptations: New challenges within the biopharmaceutical logistics have been the central issue for regulatory frameworks in improving controls over temperature and documentation. The adaptation to regulations aims at assuring even higher levels of safety and quality standards, developing more advanced logistics solutions.
• These trends drive a lot of improvements in operational efficiencies, compliances, and overall service quality in the biopharmaceutical logistics market. These advancement developments will support the emerging needs of the biopharmaceutical industry and provide further reliability to logistics operations in this market.
• Strategic Growth Opportunities for Biopharmaceutical Logistic Market
• The biopharmaceutical logistics market presents various strategic growth opportunities from several different applications, showcasing an increasing demand for advanced logistics solutions along with technological innovations.
• Cold Chain Management: Investment in advanced cold chain management solutions presents a significant growth opportunity. Technologies such as active cooling systems and real-time monitoring can ensure the integrity of temperature-sensitive products. Improved cold chain management helps ensure drugs remain within very narrow ranges of temperature limits, with minimization of waste to supply the rising demand for biologics and personalized medicine.
• E-commerce and Direct-to-Patient Delivery: With the increasing trend of e-commerce and direct-to-patient delivery models, new opportunities arise for specialized logistics providers. Efficient last-mile delivery solutions can be developed to help deal with the growing trend of home-based treatments. With this growth area comes demand for convenience and direct delivery options. Such an option would require logistics solutions that can handle complex delivery requirements and patient interactions.
• Advanced Data Analytics: Leveraging the power of advanced data analytics in the operations of logistics is an explicit growth opportunity. Analytics will further optimize logistics operations, as it would do a better job in demand forecasting, route planning, and even inventory management. Improved capabilities in data analytics will lead to efficient logistics operations, less wastage of money, and better decision-making, hence promoting the overall growth of the biopharmaceutical industry.
• Automation and Robotics : There is a huge scope for higher growth by introducing automation and robotics into logistics operations. Automated systems for warehousing, sorting, and transportation can be much more efficient and accurate. Automation reduces operation costs by reducing human errors and increases the speed of the logistics processes, hence becoming a promising investment to be undertaken by companies for smooth operations.
• Regulatory Compliance Solutions: Ensuring solutions that offer compliance with regulatory standards in constant evolution opens up an avenue of growth. It includes tracking, reporting, and maintaining quality standards through technology. Compliance solutions help logistics providers meet rigorous regulations while reducing risks associated with non-compliance and ensuring safety and productivity in the delivery of biopharmaceutical products.
• These emerging growth opportunities will be the future direction of the biopharmaceutical logistics market, either by identification and development of emerging needs or results through technological advancements. Innovation and further efficiency with reliability in biopharmaceutical logistics are driven by these emerging opportunities as the market is evolving.
• Biopharmaceutical Logistic Market Driver and Challenges
• Several technological, economic, and regulatory factors prevail, which drive the growth of the biopharmaceutical logistics market while presenting its significant set of challenges. Key drivers include technological advancement and increasing demand for biopharmaceuticals, while high implementation costs, data security, and complex regulatory compliance are some of the notable challenges. Being aware of these dynamics will thus be useful for the stakeholders in effectively traversing the market and leveraging opportunities to overcome obstacles.
• The factors responsible for driving the biopharmaceutical logistic market include:

1. Technological Advancement: IoT, AI, and blockchain are part of a wide range of technologies that can revolutionize the biopharmaceutical logistics sector. IoT sensors monitor temperature more precisely and in real time, while AI optimizes route planning and inventory management; blockchain makes every link in the chain highly transparent and traceable. These enhancements result in better efficiency, less chance for errors, and greater integrity of temperature-sensitive shipments. Therefore, they help to meet the demand for more sophisticated logistics solutions and, finally, make supply chains more reliable and efficient.

2. Increase in Demand for Biopharmaceuticals: The demand is evidently going to rise for biopharmaceutical products such as biologics and personalized medicines due to advancements in medical research, rising prevalence of chronic diseases, and an ageing global population. Correspondingly, there are an increasing number of high-value products requiring more specialized logistics that can manage the complexities of these supply chains, not least stringent temperature control and handling requirements.

3. The Gains from an Expanded Global Supply Chain: The globalization of supply chains has created the need for robust biopharmaceutical logistics solutions. Companies, while expanding into international markets, require logistics networks that are able to manage cross-border shipments and ensure that the variety of regulatory standards is met. Efficient global logistics solutions enable timely delivery and reduce disruptions-necessary to keep the biopharmaceutical product pipeline flowing and help meet the requirements of a worldwide customer base.

• Challenges in the biopharmaceutical logistic market are:

1. High Costs of Technology Implementation: Advanced technologies, such as IoT systems and blockchain, are very expensive to adopt. The costs include one-time technology investments, continuous maintenance, and integrations with existing systems. These could be entrance barriers and very costly for smaller logistics providers, therefore limiting their potential to provide high-tech solutions. This might lead to a certain digital divide between big and small market players.

2. Data Privacy and Security Issues: One of the major challenges in biopharmaceutical logistics is how to safeguard sensitive health information. Assuring data privacy and security requires proper cybersecurity measures and adherence to various regulations such as GDPR and HIPAA. Data breaches and security failures could result in legal disputes, a loss of trust, and fines. Addressing these issues requires heavy investment in security technologies and processes.

3. Complexity of Compliance with Authorities: The varied regulatory environments of different regions are indeed serious to work through for logistics providers catering to biopharmaceutical companies. Regulations pertaining to handling, documentation, and transportation could be different from country to country. Compliance with all relevant regulations requires enormous knowledge and resources. Noncompliance may lead to delays, fines, or problems of market access.

• Key drivers in the biopharmaceutical logistics market include technological development, growth in demand, and regulatory requirements, while operational efficiency and global supply chains significantly benefit. However, issues regarding high implementation costs, data security concerns, and complex regulatory compliance act as drawbacks to this market. The balance between such drivers and challenges is key for stakeholders to move with the evolution of the market and leverage opportunities for growth and innovation.
• List of Biopharmaceutical Logistic Companies
• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biopharmaceutical logistic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceutical logistic companies profiled in this report include-
• Kuehne + Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport
• Biopharmaceutical Logistic by Segment
• The study includes a forecast for the global biopharmaceutical logistic by product type, transport service type, end use, and region.

Biopharmaceutical Logistic Market by Product Type [Analysis by Value from 2018 to 2030]:

• Cold Chain Logistics
• Non-Cold Chain Logistic

Biopharmaceutical Logistic Market by Transport Service Type [Analysis by Value from 2018 to 2030]:

• Transportation
• Warehouse and Storage

Biopharmaceutical Logistic Market by End Use [Analysis by Value from 2018 to 2030]:

• Pharmaceuticals
• Biopharmaceuticals
• Pharmacies
• Hospitals
• Clinics
• Supermarkets

Biopharmaceutical Logistic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World
• Country Wise Outlook for the Biopharmaceutical Logistic Market
• Changes in regulation, technological innovations, and shifts in global demand are some of the factors that make the pace of the biopharmaceutical logistics market very fast. This particular market niche has become pivotal for safe and timely drug delivery, as a result of the nature of most biopharmaceutical products, which are sensitive either to temperature or handling conditions. Recent developments reflect the advancement of technology, increasing demand for specialized logistics solutions, and adaptation to regulatory changes across major global markets.
• United States: In the U.S., cold chain solutions are increasingly becoming advanced, integrated with digital tracking technologies. The adoption of IoT and blockchain is improving the transparency and real-time monitoring of supply chains. Regulations are changing to aim for improved compliance with safety standards, while surging demand is noticed in logistics services due to a rise in personalized medicines and biologics.
• China: The Chinese biopharmaceutical logistics market is growing rapidly due to increased focus on healthcare modernization. Investors are building basic infrastructures like temperature-controlled warehouses and advanced logistics networks. China is still at a nascent stage in developing regulations, but its government is gradually making such legislation more stringent to ensure higher quality and safety standards, thus fostering further development in this segment with increasingly sophisticated logistics solutions.
• Germany: Automation and digitization keep pace for a better service performance in German biopharmaceutical logistics. It builds high-tech warehouses to serve the customers better and develops smart transportation solutions. The strict European Union regulations are observed on the front line, with cold-chain integrity and traceability features of biopharmaceutical products.
• India: With more emphasis on infrastructure improvement and integration of technology, the Indian biopharmaceutical logistics market is growing. Specialized logistics providers offering cold chain solutions to meet the demand at the local level continue to rise in this country. Added to that, there is pressure to develop better regulatory compliance and quality control that meets international standards in support of the rapid growth of the pharmaceutical industry.
• Japan: The integration of robotics and AI to enhance efficiency and accuracy for Japan is witnessing an upsurge in biopharmaceutical logistics. Thereby, the market bears accomplished cold chain management systems along with an elevated amount of regulatory scrutiny. Japanese logistics providers are also focused on improving their digital solutions to enable better inventory management and smoothening the supply chain.
• Features of the Global Biopharmaceutical Logistic Market
• Market Size Estimates: Biopharmaceutical logistic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: Biopharmaceutical logistic market size by product type, transport service type, end use, and region in terms of value ($B).
• Regional Analysis: Biopharmaceutical logistic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, transport service types, end uses, and regions for the biopharmaceutical logistic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceutical logistic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.
• If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
• FAQ
• Q1. What is the biopharmaceutical logistic market size?
• Answer: The global biopharmaceutical logistic market is expected to reach an estimated $129.2 billion by 2030.
• Q2. What is the growth forecast for biopharmaceutical logistic market?
• Answer: The global biopharmaceutical logistic market is expected to grow with a CAGR of 7.5% from 2024 to 2030.
• Q3. What are the major drivers influencing the growth of the biopharmaceutical logistic market?
• Answer: The major drivers for this market are rising number of precision medicines and gene therapies, growing demand for household healthcare items, and augmenting trend of outsourcing logistical operations.
• Q4. What are the major segments for biopharmaceutical logistic market?
• Answer: The future of the biopharmaceutical logistic market looks promising with opportunities in the pharmaceutical, biopharmaceutical, pharmacy, hospital, clinic, and supermarket markets.
• Q5. Who are the key biopharmaceutical logistic market companies?

Answer: Some of the key biopharmaceutical logistic companies are as follows:

• Kuehne + Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport
• Q6. Which biopharmaceutical logistic market segment will be the largest in future?
• Answer: Lucintel forecasts that cold chain logistic is expected to witness the higher growth over the forecast period due to its increasing need for temperature-controlled products, necessitating precise temperature control logistics services to ensure the efficacy of the goods.
• Q7. In biopharmaceutical logistic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to expanding number of pharmaceuticals export and importation activity in the region.
• Q.8 Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceutical logistic market by product type (cold chain logistics and non-cold chain logistic), transport service type (transportation and warehouse and storage), end use (pharmaceuticals, biopharmaceuticals, pharmacies, hospitals, clinics, supermarkets, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Biopharmaceutical Logistic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biopharmaceutical Logistic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biopharmaceutical Logistic Market by Product Type
  • 3.3.1: Cold Chain Logistics
  • 3.3.2: Non-Cold Chain Logistic
• 3.4: Global Biopharmaceutical Logistic Market by Transport Service Type
  • 3.4.1: Transportation
  • 3.4.2: Warehouse and Storage
• 3.5: Global Biopharmaceutical Logistic Market by End Use
  • 3.5.1: Pharmaceuticals
  • 3.5.2: Biopharmaceuticals
  • 3.5.3: Pharmacies
  • 3.5.4: Hospitals
  • 3.5.5: Clinics
  • 3.5.6: Supermarkets
  • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biopharmaceutical Logistic Market by Region
• 4.2: North American Biopharmaceutical Logistic Market
  • 4.2.1: North American Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.2.2: North American Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.3: European Biopharmaceutical Logistic Market
  • 4.3.1: European Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.3.2: European Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.4: APAC Biopharmaceutical Logistic Market
  • 4.4.1: APAC Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.4.2: APAC Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.5: ROW Biopharmaceutical Logistic Market
  • 4.5.1: ROW Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.5.2: ROW Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Transport Service Type
  • 6.1.3: Growth Opportunities for the Global Biopharmaceutical Logistic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Region
• 6.2: Emerging Trends in the Global Biopharmaceutical Logistic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopharmaceutical Logistic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceutical Logistic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Kuehne + Nagel
• 7.2: C.H. Robinson
• 7.3: United Parcel Service
• 7.4: Deutsche Post DHL
• 7.5: Panalpina World Transport